Information on this page is updated every few minutes. You do not have to refresh your browser. It will refresh itself every couple of minutes.    NOTE: THIS WEB PAGE IS NOT UPDATED DURING MARKET HOURS.


  Last Open: 4.3500       Last Price: 4.3800     ( 0.69 %)     Total Volume: 362200 shares      Float: 65.59M shares
  High of the Day: 4.4000       Low of the Day: 4.1300      Last Price is in the top   92.59% of the day's trading range.
  Trades below current price: 89%       Volume traded below current price: 86%
  Trades during last 15 minutes: 4.19%     Trades during last hour: 13.77%    
  Volume traded during last 15 minutes: 6.63%     Volume traded During Last Hour: 18.80%    

  Short Volume traded last trading session: 187018 shares       ( 51.21 % of total volume traded )
  Short Volume traded two trading sessions ago: 458907 shares       ( 37.13 % of total volume traded )

  Current Promotion Campaign Start Date:   09/09/13
  Number of Known Previous Campaigns:   0

  Promotional Newsletters Sent       Last Hour: 0     Last Four Hours: 0     Last Eight Hours: 0     Last Sixteen Hours: 0

  Promoters Sending Newsletters During Last Hour: NONE
  One to Four Hours: NONE
  Four to Eight Hours: NONE
  Eight to Sixteen Hours: NONE

  Press Releases / News       Last Hour: 0     Last Four Hours: 0     Last Eight Hours: 0     Last Sixteen Hours: 0

Cellceutix: Prurisol(TM) for Psoriasis -- FDA Agrees That Phase 2 Study May Begin    (Wed, 10 Dec 2014 12:39:52 GMT)
Cellceutix Antibiotic Brilacidin Receives QIDP Designation From FDA    (Mon, 08 Dec 2014 12:00:00 GMT)
Transforming Biotech Coal to Gold: A Look At Puma, BioMarin and Cellceutix    (Tue, 02 Dec 2014 09:53:20 GMT)
Cellceutix: December to Be Momentous Month in Company's History    (Mon, 24 Nov 2014 12:00:00 GMT)
CELLCEUTIX CORP Financials    (Tue, 18 Nov 2014 18:04:22 GMT)
10-Q for Cellceutix Corp.    (Thu, 13 Nov 2014 00:09:27 GMT)
These Medical Stocks Are Reaching A Fever Pitch Following Midterm Elections    (Wed, 12 Nov 2014 14:41:00 GMT)
Patient Enrollment in Cellceutix Phase 2 Clinical Trial of Brilacidin-OM for Oral Mucositis Targeted to Begin in December 2014    (Tue, 11 Nov 2014 12:00:00 GMT)
CELLCEUTIX CORP Files SEC form 10-Q, Quarterly Report    (Mon, 10 Nov 2014 21:16:35 GMT)
Cellceutix's New Chief Operating Officer Dr. James Alexander Addresses Shareholders    (Fri, 31 Oct 2014 11:00:00 GMT)
CELLCEUTIX CORP Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure, Financial St    (Fri, 24 Oct 2014 10:04:28 GMT)
Cellceutix Announces Positive Top-Line Data From Phase 2b ABSSSI Trial; Single-Dose Brilacidin Comparable to 7-Days of Daptomycin    (Thu, 23 Oct 2014 15:51:09 GMT)
Cellceutix Investigational New Drug (IND) Application Becomes Effective, Selects First Site for Phase 2 Clinical Trial of New Treatment for Oral Mucositis    (Mon, 13 Oct 2014 13:00:00 GMT)
CELLCEUTIX CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits    (Wed, 24 Sep 2014 19:48:22 GMT)
Cellceutix Provides Update to Shareholders    (Wed, 24 Sep 2014 16:28:57 GMT)
Cellceutix to President Obama: We Have the Tools and Will Rise Up to the Challenge to Prevent Antibiotic Resistant Bacteria Becoming a Serious Threat to Public Health    (Fri, 19 Sep 2014 11:15:00 GMT)
CELLCEUTIX CORP Files SEC form 10-K, Annual Report    (Mon, 15 Sep 2014 17:50:04 GMT)
Cellceutix Provides Initial Observations of Completed ABSSSI Phase 2b Trial; Company Submits Investigational New Drug Application to FDA for Phase 2 Trial of Brilacidin-OM for Oral Mucositis    (Tue, 09 Sep 2014 19:00:00 GMT)
Cellceutix to Present at Rodman & Renshaw's 16th Annual Global Investment Conference    (Fri, 05 Sep 2014 15:15:46 GMT)
Cellceutix Appoints Dr. Barry Schechter to Board of Directors as Company Focuses on Meeting Requirements for Stock Exchange Uplisting    (Tue, 02 Sep 2014 11:00:00 GMT)

  Twitter Activity     Last Two Hours: 20    Last Four Hours: 33    Last Eight Hours: 49

  Tweets in the last two hours from:  @Chasing__Stars,  @IHPosts,  @stock_forums,  @IHPosts2,  @gamawupycin,  @lylitexumyn,  @zuvycefezac, 
@decadixuwoh,  @stocksecret101,  @jijujareruq,  @homicoxuloh,  @nifajoposuke,  @wavynekydyb,